Superesse SAMe Granted Japanese Joint Health Claim
The enriched yeast ingredient with S-adenosylmethionine (SAM-e) from Gnosis SpA is now approved to claim “improvement for the joint wrongness” on the Japanese market.
Photo © iStockphoto.com/Devrimb
Superesse, an enriched yeast ingredient with S-adenosylmethionine (SAM-e) from Gnosis SpA (Desio, Italy), can now carry a joint-health claim in Japan. The Japanese Ministry of Health, Labour and Welfare (MHLW) has granted Superesse the health claim of “improvement for the joint wrongness,” based in part on the strength of its research profile for reducing knee discomfort, according to Gnosis.
“For regulatory purposes, nutraceuticals in Japan are heavily regulated, so achieving a health claim in Japan is extremely hard,” said Paulo Malesani, commercial director of Gnosis Group. “But that confirms that Superesse’s outstanding nutritional value has been recognized for the improvement of joint wrongness.”
Read more:
Ingredient Spotlight: S-Adenosylmethionine (SAM-e)
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
